Intelligent
GILF Shortlisted in Catalog of Guangdong's Nationwide Trade Initiative (2025), Starting New Procurement Season in March
ZHONGSHAN,China,Feb. 25,2025-- Recently,the official website of the Department of Commerce of Guangdong Province released the Catalog of Guangdong\'s Nationwide Trade Initiative (2025). After submissi
Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs
HONG KONG,Feb. 25,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab,Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a c
YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)
SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr
Yatsen Announces Fourth Quarter and Full Year 2024 Financial Results
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on February 25,2025 GUANGZHOU,China,Feb. 25,2025--Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG),a leading
Foxit Supercharges AI Assistant with Multi-Document Analysis on iOS & Android
Enables Users to Boost Productivity with AI-Powered Summaries,Cross-Document Insights,and Instant Data Extraction Across Mobile Device
Vialto Partners Completes Recapitalization Transaction
Transaction Completely and Definitively Transforms Vialto\'s Capital Structure,Delivering a $225 Million New Money Equity Capital Investment in Vialto and a Reduction of Approximately $550 Million of
Axiad Applauded by Frost & Sullivan for Providing Phishing-resistant Authentication with PKI-based Authentication
Axiad\'s PKI-based authentication enables scalability and flexibility in large-scale enterprise environments,elevates user experience and streamlines user access control
CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China
SHANGHAI,Feb. 25,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK,"CARsgen Therapeutics"),a company focused on innovative CAR T-cell therapies for the treatment of hematolo
Keypoint Intelligence Releases New Insights on the Future of the Document Scanner Market
FAIRFIELD,N.J.,Feb. 25,2025--Keypoint Intelligence,a leading provider of digital imaging market research,has released two new reports offering critical insights for the document scanner industry: Nor
MediBeacon® Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.